Hirsch Andrew (CIK 1586707) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-18). Recent activity: Buy CCCC (700,000 shares), Buy CCCC (81,725 shares), Sell CCCC (39,154 shares), Buy CCCC (20,400 shares), Sell CCCC (9,057 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | President & CEO | Buy | 700,000 | $0 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | President & CEO | Buy | 81,725 | $0 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | President & CEO | Sell | 39,154 | $74,001 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | President & CEO | Buy | 20,400 | $0 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | President & CEO | Sell | 9,057 | $17,118 |
| 2025-02-18 | C4 Therapeutics, Inc. (CCCC) | President & CEO | Buy | 223,500 | $0 |
| 2025-02-18 | C4 Therapeutics, Inc. (CCCC) | President & CEO | Sell | 12,847 | $40,853 |
| 2025-02-18 | C4 Therapeutics, Inc. (CCCC) | President & CEO | Sell | 9,370 | $29,797 |
Source: SEC Form 4 filings · as of 2026-02-18